从经济角度看仅MRI放疗:前列腺癌治疗中的新技术能否节省成本
本研究以瑞典临床实施的仅MRI放疗流程为模板,与CT/MRI联合工作流进行成本比较,成本取自2021年官方区域价目表。对10例前列腺癌患者(处方78 Gy/39次)制定5-10 mm margins的计划,结果显示排除CT检查和更快的靶区勾画是成本降低的主要因素。长期仅MRI每例患者节省209欧元,缩小margins额外节省46欧元/例,但短期因QA程序额外成本,成本降低有限(14欧元/例)。
要点
- 排除CT检查和更快的靶区勾画是成本降低的主要贡献因素。
- 额外QA程序使初始成本降低限于每例患者14欧元。
- 长期仅MRI每例患者节省209欧元。
核心结论
- 当工作流任务更高效且因缩小margins减少副作用时,仅MRI工作流实施与成本降低相关。
- 由于QA程序的额外成本,短期经济效益有限。
- 仅MRI的经济效益只有在工作流成熟且纳入margins缩小后才会首先显现。
研究设计与样本
- 以瑞典临床实施的仅MRI放疗为模板进行成本评估,与CT/MRI联合工作流比较。
- 成本取自2021年官方区域价目表。
- 假设初始阶段需要仅MRI特定QA。
- 为10例前列腺癌患者(处方78 Gy/39次)创建靶区margins为5-10 mm的治疗计划。
- 使用QUANTEC推荐的NTCP模型计算≥2级直肠毒性或直肠出血风险,并基于后续诊断检查估算成本。
主要发现
- 排除CT检查和更快的靶区勾画是成本降低的主要贡献因素。
- 额外QA程序使初始成本降低限于每例患者14欧元。
- 长期仅MRI每例患者节省209欧元。
- margins缩小至7 mm时≥2级直肠毒性或直肠出血概率为9.7%,5 mm时为6.0%。
- margins缩小额外节省每例患者46欧元。
关键数值与推荐
- 处方剂量78 Gy分39次。
- 靶区margins为5-10 mm。
- 7 mm margin时≥2级直肠毒性或直肠出血概率9.7%。
- 5 mm margin时≥2级直肠毒性或直肠出血概率6.0%。
- 长期仅MRI每例患者节省209欧元,margins缩小额外节省46欧元/例,初始QA限制成本降低至14欧元/例。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: The aim of this study was to analyze a magnetic resonance imaging (MRI)-only radiotherapy workflow from an economic perspective in terms of reduced time, costs and systematic uncertainties. MATERIAL/METHODS: A documented Swedish clinical implementation of MRI-only radiotherapy was used as template for cost assessments compared to a combined computed tomography (CT)/MRI workflow. The costs were taken from official regional price lists from 2021. MRI-only specific quality assurance (QA) was assumed necessary in an initial phase. Treatment plans for target volumes with margins of 5-10 mm were created for ten prostate cancer patients prescribed 78 Gy in 39 fractions. The risk of Grade ≥ 2 rectal toxicity or rectal bleeding was calculated using the QUANTEC recommended NTCP model and costs estimated based on subsequent diagnostic examinations. RESULTS: The exclusion of the CT-examination and faster target delineation were the main contributors to cost reductions. Additional QA procedures limited the initial cost reduction to 14 EUR/patient. Long-term MRI-only reduced the costs by 209 EUR/patient. Reducing margins resulted in Grade ≥ 2 rectal toxicity or rectal bleeding probability of 9.7 % for 7 mm margin and 6.0 % for 5 mm margin. This margin reduction resulted in an additional cost reduction of 46 EUR/patient. CONCLUSION: An MRI-only workflow implementation is associated with reduced costs when the workflow tasks are more time efficient and side effects are reduced as a result of margin reduction. The short-term economic benefits are limited due to extra costs of QA procedures. The economic benefits of MRI-only will make impact first when the workflow is well established, and margin reduction has been included.
引用
- Persson E, Svanberg N, Scherman J, et al. MRI-only radiotherapy from an economic perspective: Can new techniques in prostate cancer treatment be cost saving? Clin Transl Radiat Oncol. 2022. PMID: 36479236. doi:10.1016/j.ctro.2022.11.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。